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Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys by Klahr and colleagues [1, 2]. UUO is an excellent
with unilateral ureteral obstruction. model of interstitial fibrosis because it is normotensive,
Background. The small GTPase Rho is involved in cell-to- non-proteinuric and non-hyperlipidemic, without anysubstratum adhesion and cell contraction. These actions of Rho
apparent immune or toxic renal insult. The molecularmediated by downstream Rho effectors such as Rho-associated
and cellular mechanism(s) of interstitial fibrosis in thecoiled-coil forming protein kinase (ROCK) may be partly re-
sponsible for the progression of renal interstitial fibrosis. UUO kidney are beginning to be elucidated. The me-
Methods. The anti-fibrosis effects of Y-27632, a specific ROCK chanical disturbance resulting from ureteral ligation
inhibitor, were studied both in vivo (unilateral ureteral obstruc-
(tension stress) [3], hypoxia induced by a marked declinetion; UUO) and in vitro. To investigate the therapeutic efficacy
in renal plasma flow [2], up-regulation of monocyte che-of Y-27632 in UUO kidneys, smooth muscle  actin (SMA)
expression, macrophage infiltration and fibrosis in the obstructed moattractant peptide [4], osteopontin [5], intercellular
kidneys were studied. SMA, transforming growth factor  adhesion molecule 1 (ICAM-1) [6] and heat shock pro-
(TGF-), 1 (I) collagen, osteopontin, macrophage chemoat- tein 47 [7, 8], macrophage influx into the interstitiumtractant peptide-1 (MCP-1), and intercellular adhesion mole-
[4, 9], production of macrophage-derived cytokines, es-cule-1 (ICAM-1) gene expression were examined by Northern
pecially transforming growth factor- (TGF-) [10, 11],blotting. To elucidate the mechanism linking the Rho-ROCK
pathway with renal fibrosis, the effects of Y-27632 on in vitro vasoconstrictors such as angiotensin II (Ang II) [12, 13],
cell proliferation and cell migration were studied. endothelin [14], and oxidative stress [15, 16] have been
Results. In vivo analysis showed that Y-27632 suppressed shown to play important roles in tubulointerstitial dam-SMA expression, macrophage infiltration and interstitial fi-
age in the UUO kidney.brosis, and that Y-27632 suppressed SMA, TGF- and 1 (I)
collagen mRNA expression. In vitro analysis showed that Y-27632 Among more than 50 Ras-related small GTPases, Rho
did not suppress proliferation of renal fibroblasts but sup- was the first to be identified [17] and has been most
pressed migration of macrophages. extensively studied. Rho is known to function as a molec-
Conclusions. The Rho-ROCK system may play an impor-
ular switch in various cellular functions including forma-tant role in the development of tissue fibrosis, and the Rho-
tion of stress fibers and focal adhesions [18], regulationROCK signaling pathway may be a new therapeutic target for
preventing interstitial fibrosis in progressive renal disease. of calcium ion sensitivity in smooth muscle cells [19],
regulation of cytokinesis following nuclear division [20]
and regulation of G1 to S cell cycle progression [21]. Al-
Renal interstitial fibrosis is one of the common histo- though little is known about its mode of action, Rho is
pathological features of progressive renal disease of di- activated by stimulants such as lysophosphatidic acid, plate-
verse etiology. Chronic unilateral ureteral obstruction let derived growth factor (PDGF) [18], Ang II [22, 23] and
(UUO) is a well-characterized experimental model of re- endothelin [24]. Activated Rho binds to specific targets,
nal injury leading to tubulointerstitial fibrosis, pioneered called effectors, which results in various cellular functions.
Among these Rho effectors, Rho-associated coiled-coil
forming protein kinase (ROCK) is the best characterized.Key words: Rho-ROCK pathway, tissue fibrosis, renal fibrosis, progres-
sive renal disease, tubulointerstitial fibrosis, cell proliferation. As a specific inhibitor of ROCK, Uehata and col-
leagues reported a synthetic compound named Y-27632Received for publication March 14, 2001
in 1997 [25]. Y-27632 inhibits ROCK by binding to theand in revised form December 19, 2001
Accepted for publication December 20, 2001 catalytic site, and its affinities for ROCK as determined
by Ki values are 0.22 mol/L for ROCK-1 and 0.30 2002 by the International Society of Nephrology
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mol/L for ROCK-2, which are at least 10- to 20-fold described by Muller and colleagues [27] with slight modi-
higher than those of two other Rho effector kinases, fications. The renal cortex was dissected from the kidney,
citron kinase and protein kinase N [26]. Y-27632 is stable minced and suspended in Dulbecco’s modified Eagle’s
in saline at room temperature at least 4 weeks but is medium (DMEM; Sigma, St. Louis, MO, USA) supple-
metabolized rapidly in vivo. Tissue accumulation has not mented with 10% fetal calf serum (FCS; Cell Culture
been reported and oral administration of Y-27632 (100 Laboratories, Cleveland, OH, USA). Cells were incu-
mg/kg/day) to SD rats for 4 weeks caused no major side bated on collagen-coated plastic dishes (Iwaki, Chiba,
effects such as leukopenia (data not shown). Japan) at 37C in 5% CO2. After two to three passages,
While cellular functions and signal transduction of only fibroblasts survived under these culture conditions.
Rho have been extensively studied, information regard- RAW 264.7, a mouse macrophage cell line, were ob-
ing its in vivo functions is still limited. tained from ATCC (Rockville, MD, USA). Cells were
In the present study, we hypothesized that the actions maintained in DMEM supplemented with 10% FCS at
of Rho may be partly responsible for the progression of 37C in 5% CO2.renal interstitial fibrosis and examined this hypothesis
by blocking the Rho-ROCK signaling pathway by admin- Measurement of drug concentration
istration of Y-27632. We demonstrated that tubulointer-
The concentrations of Y-27632 in serum were mea-stitial fibrosis was ameliorated by Y-27632 administration
sured by high-pressure liquid chromatography (HPLC).along with the suppression of myofibroblast expansion
To serum (0.2 mL) was added 0.2 mL of sodium hydrox-and macrophage infiltration.
ide (1 mol/L) followed by extraction with 2.0 mL of
chloroform. The organic layer was evaporated at 40C
METHODS and was redissolved in 200 L of mobile phase, and was
In vivo experimental protocol and disease model injected into the L-7000 HPLC system (Hitachi, Tokyo,
Japan). Separation was achieved on a reversed-phaseThis study was designed to determine whether Y-27632
column C18 UG-120 n, a Ca pcell pak S-5 (150 mm improves tubulointerstitial fibrosis of the kidneys with
4.6 mm I.D.; Shiseido, Tokyo, Japan) at 40C. The mobileunilateral ureteral obstruction. Male BDF1 mice (19 to
phase was methanol-20 mmol/L sodium perchlorate ad-24 g) were maintained on tap water with sucrose (30%
justed to pH 2.5 with perchloric acid (1:9, vol/vol). Thevol/wt) and standard chow (CRF-1; Oriental Yeast, Co.
samples were eluted at a constant flow rate of 1.0 mL/Ltd., Tokyo, Japan). Protocols were approved by Osaka
University Medical School Animal Care and Use Com- min, and the UV detector (L-7400, Hitachi) was set at
mittee and were performed according to the Osaka Uni- 270 nm.
versity Medical School Guideline for the Care and Use of
Tissue preparationLaboratory Animals. Mice were divided into two groups:
vehicle control (N  10), and those given Y-27632 (N  Kidney sections were fixed in a cold 4% paraformalde-
15). Y-27632 (a generous gift from Mitsubishi Pharma hyde (for Masson’s trichrome staining and F4/80 detec-
Corporation, Osaka, Japan) is readily soluble in water, tion) or methacarn solution (methanol 60%, chloroform
and was added to the drinking water (200 mg/L) from 30%, acetic acid 10%) for smooth muscle  actin (SMA)
two days before UUO operation until the day of sacrifice. detection for 16 to 24 hours, and embedded in paraffin
The average water intake of five mice was measured on or Tissue-Tec O.C.T. compound (Sakura Finetechnical
alternate days, and the inferential dosage of Y-27632 Co Ltd., Tokyo, Japan). Three-micrometer thick paraffin
was calculated. sections were subjected to Masson’s trichrome staining
The general procedure of the unilateral ureteral ob- and SMA detection, and 4-m thick cryosections were
struction (UUO) operation was as described previously used for F4/80 detection.
[8]. For immunohistochemical labeling and RNA extrac-
tion, both obstructed and contralateral unobstructed kid- Immunohistochemical study
neys were harvested from UUO animals at 4 and 10
Smooth muscle alpha actin and monocyte/macrophagesdays after ureteral obstruction (N  5; each group).
were identified with mouse anti-SMA monoclonal anti-Midcoronal sections of the kidneys were also taken for
body (1A4) (EPOS, peroxidase-conjugated; Dako, Den-immunohistochemical labeling. For the measurement of
mark) and biotinylated rat anti-mouse F4/80 antigen mono-serum concentration of Y-27632, UUO animals were
clonal antibody (Serotec Ltd., Oxford, UK), respectively.sacrificed at 7 days after ureteral obstruction (N  5;
Immunohistochemical detection of SMA and F4/80 an-Y-27632-treated group only).
tigen was performed as previously described [15]. Nor-
Cell culture mal mouse and rat serum were used for negative controls
for SMA and F4/80 staining respectively. No significantPrimary mouse renal fibroblasts were generated ac-
cording to the method for human renal fibroblast culture staining was observed in the negative controls.
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Table 1. Design of the primers
Sense primer Antisense primer Product size bp
RhoA 5-CCAGTTCCCAGAGGTCTATGT-3 5-GCGCCAATCCTGTTTGCCATA-3 375
RhoB 5-AAGACGTGCCTGCTGATCGTG-3 5-CTTGCAGCAGTTGATGCAGCC-3 531
RhoC 5-CGACATCGAAGTGGATGGCAA-3 5-GGGAAGTCAGAGAATGGGACA-3 457
TGF- 5-AAGACCATCGACATGGAGC-3 5-TGTCACAAGAGCAGTGAGCG–3 580
Osteopontin 5-ATGAGATTGGCAGTGATTTG-3 5-ATGCTCAAGTCTGTGTGTTT–3 681
MCP-1 5-AGCCAACTCTCACTGAAGCC–3 5-CATTCAAAGGTGCTGAAGACC–3 256
ICAM-1 5-TAAGAGGACTCGGTGGATGG-3 5-ATGAGGCTCGATTGTTCAGC-3 550
RNA isolation Northern blotting
RNA (10g from cultured cells and 20g from a wholeRNA of cultured renal fibroblasts, which were treated
kidney) was size-fractionated on 1% agarose-formalde-with Y-27632 (0, 1, 10 or 100 mol/L), was isolated from
hyde gels and transferred onto nylon membrane filterssubconfluent monolayers in TRIzol reagent (5 mL for a
(Hybond N; Amersham, Boston, MA, USA). RNA blotsdish; Gibco BRL, Gaithersburg, MD, USA) and for RNA
were performed by standard techniques with the 32P-isolation from a whole kidney, tissue was homogenized
labeled cDNA probes described below. The densities ofwith a Polytron homogenizer (Kinematica, Switzerland)
the bands were quantified with the computing densitom-in TRIzol reagent (4 mL per kidney). Total RNA was
eter Image Quant (Molecular Dynamics, Sunnyvale, CA,prepared by the acid guanidinium isothiocyanate-phe-
USA). The following 32P multi-prime-labeled DNA probesnol-chloroform extraction procedure according to the
for 1 (I) collagen [8], TGF-, osteopontin, macrophagemanufacturer’s instructions [28].
chemoattractant peptide-1 (MCP-1), ICAM-1, and glyc-
Reverse transcription eraldehyde-3-phosphate-dehydrogenase (GAPDH) were
prepared using the rediprime DNA labeling system (Amer-Reverse transcription (RT) was performed as follows:
sham, Buckinghamshire, UK). The designs of primersto 0.4 g of total RNA from whole kidney was added
of TGF-, osteopontin, MCP-1 and ICAM-1 are shown4 L first-strand RT buffer (final concentration of 50
in Table 1. Partial cDNAs used as probes were preparedmmol/L tris (hydroxymethyl) aminomethane (Tris) hy-
by reverse transcription polymerase chain reaction (RT-drochloride, pH 8.3, 75 mmol/L KCl, and 3 mmol/L
PCR) using primers and mouse kidney RNA as tem-MgCl2), 2.5L H2O, 0.5L RNase inhibitor (55 U), 1 L
plates. cDNA amplified by RT-PCR with these primersof 10 mmol/L deoxynucleotide mixture, 1 L random
was subcloned using a pSTBlue-1 vector kit (Novagen,primer [0.02 A260 absorbance units of hexadeoxyribo- Milwaukee, WI, USA). Oligonucleotide probe of thenucleotide mixture (p(dN)6) per reaction], 2 L of 0.1 mouse SMA: 5-CACGAGTAACAAATCAAAGCTmol/L dithiothreitol (DTT) and 1 L Moloney murine
TTGGG CAGGAATGATTTGGAAAGGAACTGGleukemia virus reverse transcriptase (MMLV transcript-
AGGCGCTGA TCCACAAAACGTTCACAGTTGTase; Gibco BRL). Reaction tubes were incubated at 30C
GTGCTA-3 was labeled with T4 polynucleotide kinase
for 10 minutes and 42C for 40 minutes. At the end of using [	 32P] ATP (3,000 Ci/mmol; Amersham).
the incubation, the reaction was stopped by heating at
95C for 5 minutes to inactivate the MMLV. Morphometric analysis of the interstitial fibrosis in
Masson’s trichrome or immunohistochemically stained
Polymerase chain reaction sections using a computer-aided manipulator
Polymerase chain reaction (PCR) was performed as The area of the fibrotic lesion of cortical interstitium
follows: to 1 L of the RT reaction mixture was added was determined on sections stained by Masson’s trichrome
0.4 L of 10 mol/L forward and reverse primer, 2 L method to stain the collagen fibers (stained in blue) using
of 10  buffer (final concentration of 10 mmol/L Tris computer-aided manipulator program, Macscope (Mi-
HCl, pH 8.3, 50 mmol/L KCl, 1.5 mmol/L MgCl2 and tani Corporation, Fukui, Japan), as described previously
0.001% gelatin), 14.5 L H2O, 1.6 L of 2.5 mmol/L [8]. The interstitial area positive for immunohistochemi-
dNTP mix and 0.1 L of Taq polymerase. The design cal detection was analyzed and quantified as described
of RhoA, RhoB and RhoC primers are shown in Table 1. [16, 29]. The scores of ten fields of each kidney were
Twenty-five cycles of sequential steps were performed averaged, and the scores of five separate animals were
using a terminal cycler; PCR System 9700 (Perkin Elmer, then averaged.
Wellesley, MA, USA) using the following parameters:
Cell proliferation assaydenaturation at 95C for one minute, annealing at 58C
for one minute, extension at 72C for two minutes, fol- Cell proliferation was assessed using the MTT [3,(4,
5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide]lowed by a final incubation at 72C for seven minutes.
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Fig. 1. mRNA expression in unilateral ure-
teral obstructed (UUO) mouse kidney 4 days
after surgery. Results of RT-PCR of RNA
from UUO mouse kidneys 4 days after surgery
are shown. Each lane represents RT-PCR
product from vehicle-treated obstructed kid-
neys (lanes 1 to 4) and contralateral kidneys
(lanes 5 to 8).
method modified by Hansen, Nielsen and Berg [30]. Re- Bartlett’s test. The statistical significance of any in-
nal fibroblasts (p8, 4  103 cells/well) were introduced tergroup differences was determined using Dunnett’s
to 96-well plates. After 24 hours of serum starvation, test for homogeneous data or Kruskal-Wallis test fol-
DMEM containing 0.5% or 10% FCS and different con- lowed by Dunnett’s type test for heterogeneous data.
centrations of Y-27632 (0, 2, 20, 200 or 2000 mol/L) was Statistically significant differences between groups were
added. Twenty-four hours later, MTT (Sigma) was added defined as P values less than 0.05.
to each well, and after a two hour incubation, extraction
buffer [20% wt/vol of SDS dissolved in 50% N,N-dimethyl
RESULTSformaldehyde (DMF) solution, pH 4.7] was added. After
Drug delivery in UUO miceovernight incubation, the optical densities at 595 nm were
measured using an Emax precision microplate reader Y-27632 was administered to mice orally by adding to
(Molecular Devices, Sunnyvale, CA, USA). the drinking water. During a series of experiment, there
was no dropout due to death. In the preliminary experi-
Cell migration assay ment, water intake was significantly reduced in the
Migration of cultured macrophages was assayed using Y-27632-treated group possibly due to the bitter taste
Cell Culture Insert with a pore size of 8.0 m (Becton of the drug. To overcome this problem, sucrose was
Dickinson, Franklin Lakes, NJ, USA). RAW 264.7 cells added to the drinking water. Consequently, water intake
(2  105 cells) were introduced onto the insert. Cells of vehicle-treated mice became 4.50 
 0.46 mL/day and
were pre-incubated with DMEM containing 0.5% FCS that of Y-27632-treated animals became 4.42 
 0.48 mL/
or C3 exoenzyme (Biomol Research Laboratories Plym- day; the difference was not significant. Daily water intake
outh Meeting, PA, USA) for 24 hours. Serum-free in the Y-27632-treated group resulted in drug ingestion
DMEM containing either MCP-1 (2.5 ng/mL or 25 of about 40 mg/kg/day. The serum concentration of
ng/mL; Sigma) or Ang II (1 mol/L; Sigma) was added Y-27632 was 215.2 
 82.3 ng/mL (0.64 mol/L), which
to the insert (0.4 mL) and the bottom chamber (1.4 mL) was similar to the reported Ki value of Y-27632 toward
with Y-27632 (0, 10 or 100 mol/L). After a 24-hour ROCKs in vitro.
incubation, cells were fixed with methanol for 10 minutes
and stained with Giemsa for 30 minutes at room temper- Expression of Rho mRNA in UUO kidneys
ature. The number of cells that remained on the inner
Expression of RhoA, RhoB and RhoC mRNA foursurface of the insert and that had moved to its outer side
days after ureteral obstruction was examined by RT-PCR.through the pores was counted under a light microscope
While RhoA mRNA expression was not significantly dif-by changing the focus. Ten individual microscopic fields
ferent between UUO and contralateral kidneys, expres-(400) were selected at random in each section. Three
sion of RhoB and RhoC mRNA was up-regulated in UUOindividual experiments were performed. The scores of
kidneys (Fig. 1).the ten fields of each section were averaged, and the
scores of three separate experiments were then averaged.
Effects of Y-27632 on interstitial expansion ofThe proportion of migrated cells (Migration Index) was
UUO kidneyscalculated as follows: Migration Index (%)  Cell num-
The representative appearance of Masson’s trichrome-ber on outer side/Cell numbers on both sides  100 [31].
stained sections 10 days after ureteral obstruction is
Analytical procedure shown in Figure 2A. Interstitial expansion of obstructed
kidneys was prominent in vehicle-treated animals (Fig.All values are expressed as means 
 standard devia-
tion. The data were analyzed for homogeneity using 2A, I). In Y-27632-treated animals, interstitial expansion
Fig. 2. Masson’s trichrome staining of kid-
neys from both experimental groups at 4 and
10 days after ureteral obstruction and quanti-
tative analysis of interstitial fibrosis. (A) Light-
field photomicrographs of Masson’s trichrome-
stained sections of renal cortical region from
(I ) vehicle and (II ) Y-27632-treated mouse
obstructed kidneys 10 days after ureteral
obstruction and (III ) contralateral kidneys
(400). (B) Interstitial fibrosis was quantified
with a computer-aided image manipulator.
Five animals were analyzed for each group
and 10 randomly selected high power fields
were quantified and averaged to obtain the
value for each animal. (C ) Light-field photo-
micrographs of Masson’s trichrome-stained
sections of renal cortical region from (I ) ve-
hicle and (II ) Y-27632-treated mouse ob-
structed kidneys 4 days after ureteral obstruc-
tion and (III ) contralateral kidneys (400).
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was less than that in vehicle-treated controls and the nificant (data not shown). Expression of osteopontin,
MCP-1 and ICAM-1 mRNA 4 and 10 days after ureteraltubular back-to-back structure was relatively well pre-
served (Fig. 2A, II). Y-27632 treatment significantly obstruction was examined to assess the production of
chemokines, which are closely related to fibrosis in theameliorated the interstitial expansion in UUO kidneys
at 10 days after ureteral obstruction to 47% of that in UUO kidney. Only marginal suppression (less than 17%)
of chemokine expression was observed in Y-27632-vehicle-treated controls (Fig. 2B). The effect of Y-27632
treatment on UUO kidneys after four days was not sig- treated mice (Fig. 5A and Table 2).
nificant (Fig. 2C).
Effects of Y-27632 on mouse renal
fibroblast proliferationEffects of Y-27632 on interstitial SMA expression in
UUO kidneys We examined whether Y-27632 suppresses cell prolif-
eration. MTT assay indicated that Y-27632 did not showInduction of interstitial myofibroblasts was assessed
by immunohistochemical detection of SMA. Positive an inhibitory effect on proliferation of mouse renal fi-
broblasts even at a dose of 200 mol/L, and showedstaining for SMA was seen in vascular smooth muscle
cells, but not in the interstitial space in the contralateral cytotoxicity at a dose of 2,000 mol/L (Fig. 6).
kidney (Fig. 3A, III). Intense immunostaining of SMA
Effects of Y-27632 on macrophage migrationwas observed in periglomerular and peritubular intersti-
tium in addition to the vascular smooth muscle cells of While histological assessment showed that macrophage
infiltration was significantly reduced in the Y-27632–the arterioles in vehicle-treated mouse kidneys 10 days
after ureteral ligation (Fig. 3A, I). Y-27632 treatment treated group, Northern blot analyses showed that
Y-27632 did not suppress typical macrophage chemokinereduced the appearance of SMA-positive myofibro-
blasts in the interstitium (Fig. 3A, II). The result of quan- mRNA expression. Therefore, we examined whether
Y-27632 directly suppressed macrophage motility.titative analysis of SMA immunostaining are shown in
Figure 3B). Y-27632 significantly reduced SMA immu- Y-27632 abrogated MCP-1–induced macrophage mi-
nostaining at 10 days after ureteral obstruction to 50% gration in a dose-dependent manner, indicating the in-
of that in vehicle-treated controls. volvement of Rho in cell motility. This is supported by
the fact that C3 exoenzyme, inhibitor of Rho, also abro-
Effects of Y-27632 on macrophage infiltration in the gated MCP-1–mediated migration of macrophage (Fig.
interstitium of UUO kidneys 7A). We also examined whether Ang II stimulates che-
Figure 4A shows the representative appearance of im- motaxis. As shown in Figure 7B, Ang II stimulated mac-
munostaining for F4/80, a macrophage marker, in the rophage migration and it was significantly suppressed by
UUO kidneys 10 days after ureteral obstruction in both Y-27632.
experimental groups. At 10 days following ureteral ob-
struction, macrophage infiltration was observed in the
DISCUSSIONperiglomerular and peritubular interstitium of the ob-
The possible involvement of Rho signal transductionstructed kidneys from vehicle-treated mice (Fig. 4A, I).
in the pathogenesis of progressive tissue damage includ-This was reduced in Y-27632-treated animals (Fig. 4A,
ing kidney disease has not been well investigated. ThisII). Quantitative analysis of the F4/80-positive area in
is the first trial to examine the pathophysiological sig-the interstitium is shown in Figure 4B. Significant reduc-
nificance of Rho in kidney disease. We hypothesized thattion of the F4/80-positive area was observed in Y-27632
Rho signal transduction is related to cell migration andtreated mouse kidneys to 51% of that in vehicle-treated
proliferation in the lesions of progressive fibrosis. Thecontrols.
present study was performed to elucidate whether Rho
Effects of Y-27632 on mRNA expression in obstructed signal transduction is involved in the process of renal
kidneys and cultured renal fibroblasts fibrosis, and if so, to assess the therapeutic value of
Y-27632, a specific ROCK inhibitor.Expression of1(I) collagen, SMA and TGF-mRNA
We focused on tubulointerstitial lesions employing4 and 10 days after ureteral obstruction was examined
UUO model mice because tubulointerstitial injury in-to elucidate the effects of Y-27632 on fibrosis-related
variably is found in the chronically diseased kidney, irre-gene expression. Significant reductions were seen in
spective of the type of disease or the compartment in1(I) collagen, SMA and TGF- mRNA levels in the
which the disease originated, and recent investigationsY-27632-treated group (Fig. 5A and Table 2). Y-27632
revealed close association between interstitial damagetreatment also reduced expression of SMA mRNA in
and the prognosis of renal dysfunction [32, 33].cultured renal fibroblasts in a dose-dependent manner
The expression of RhoB and RhoC mRNA was up-(Fig. 5B), but reductions of 1(I) collagen and TGF-
mRNA levels in cultured renal fibroblasts were not sig- regulated in UUO kidneys. Although pathophysiological
Fig. 3. Immunohistochemical detection and quan-
titative analysis of smooth muscle  actin (SMA)
in obstructed kidneys 10 days after surgery. (A)
Light-field photomicrographs of the renal cortical
region reacted with mouse monoclonal anti-SMA
antibody from (I ) vehicle-treated and (II ) Y-27632-
treated mouse obstructed kidneys 10 days after ure-
teral obstruction and (III ) contralateral kidneys.
Sections were counterstained with methylgreen
(400). (B) The SMA-positive area was quanti-
fied with a computer-aided image manipulator. Five
animals were analyzed for each group and 10 ran-
domly selected high power fields were quantitated
and averaged to obtain the value for each animal.
Fig. 4. Immunohistochemical detection and quan-
titative analysis of F4/80 in obstructed kidneys 10
days after surgery. (A) Light-field photomicro-
graphs of the renal cortical region reacted with
mouse monoclonal anti-F4/80 antibody from (I )
vehicle-treated and (II ) Y-27632-treated mouse
obstructed kidneys 10 days after ureteral obstruc-
tion. Sections were counterstained with methyl-
green (400). (B) The F4/80-positive area was
quantified with a computer-aided image manipu-
lator. Five animals were analyzed for each group
and 10 randomly selected high power fields were
quantified, and averaged to obtain the value for
each animal.
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Fig. 5. mRNA expression in UUO mouse
kidney 10 days after surgery and in mouse
renal fibroblasts. (A) Representative results of
Northern blotting of RNA from UUO mouse
kidneys 10 days after surgery are shown. Each
lane represents 20 g of RNA from vehicle-
treated obstructed kidneys (lanes 1 and 2),
Y-27632-treated obstructed kidneys (lanes 3
and 4), and vehicle-treated contralateral kid-
neys (lanes 5 and 6). (B) Representative re-
sults of Northern blotting of RNA from mouse
renal fibroblasts are shown. Each lane repre-
sents 10 g of RNA treated with Y-27632 at 0
mol/L (lane 1), 1 mol/L (lane 2), 10 mol/L
(lane 3) or 100 mol/L (lane 4).
functions of RhoB and RhoC are largely unknown com- It is also reported that overexpression of RhoC enhances
tumor metastasis [36]. Since up-regulation of RhoB andpared with RhoA, it has been reported that RhoB was
induced by PDGF and epidermal growth factor in rat RhoC possibly plays an important role in the progression
of interstitial fibrosis in UUO kidney, it is important tofibroblast [34] and that RhoB regulates apoptosis [35].
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Table 2. mRNA expression in mouse kidneys 4 and 10 days after the onset of ureteral obstruction
4 day 10 day
Vehicle Y-27632 P Vehicle Y-27632 P
1 (I) collagen 1
0.184 0.705
0.065 0.05 1
0.196 0.555
0.224 0.05
SMA 1
0.182 0.743
0.074 0.05 1
0.130 0.587
0.130 0.005
TGF- 1
0.184 0.537
0.095 0.005 1
0.167 0.523
0.236 0.01
Osteopontin 1
0.159 0.891
0.073 1
0.080 0.866
0.074 0.05
MCP-1 1
0.281 0.861
0.111 1
0.230 0.909
0.199
ICAM-1 1
0.285 0.831
0.101 1
0.195 1.045
0.176
Data are: N  5, mean 
 SD. Relative induction of 1 (I) collagen, SMA, osteopontin, MCP-1, ICAM-1 and TGF- mRNA by densitometry of the Northern
blotting autoradiograms. The densitometoric values of vehicle treated mice were taken as 1. Results are mean 
 standard deviation of 5 independent animals.
Fig. 6. Cell proliferation in mouse renal fibroblasts. Inhibitory effects
of Y-27632 on proliferation of normal BDF1-derived renal fibroblasts
(p9) as determined by MTT incorporation. Results are means 
 SD of
5 independent experiments. * P  0.001 vs. vehicle-treated fibroblast.
elucidate how these signal transduction pathways affect
in UUO kidney in detail.
In the present study, interstitial fibrosis in UUO kid-
neys was significantly reduced by Y-27632 administra-
tion, which was accompanied by suppression of both
SMA expression and macrophage infiltration. The ap-
pearance of SMA-positive activated interstitial cells is
one of the early changes leading to fibrosis in the tubu-
lointerstitium. The enhanced expression of SMA is a Fig. 7. Cell migration in mouse macrophages. (A) Inhibitory effects of
Y-27632 on migration of RAW 264.7 mouse macrophages stimulatedmarker of interstitial phenotypic change in various forms
by MCP-1 at 2.5 ng/mL () and 25 ng/mL ( ). (B) Inhibitory effectsof renal disease and these activated interstitial cells are
of Y-27632 on migration of RAW 264.7 mouse macrophages stimulated
called ‘myofibroblasts’ [37]. The appearance of myofi- by Ang II 1 M (). Results are means 
 SD of 3 independent experi-
ments. * P  0.001, P  0.005 and P  0.001 vs. correspondingbroblasts also has been considered to play a key role in
vehicle-treated macrophages.the progression of renal fibrosis in interstitial lesions
[29, 38]. In the present study, reduced SMA expression
was confirmed not only by immunohistochemical detec-
tion, but also by Northern blotting using whole kidneys differentiation marker expression, while it plays a much
and cultured renal fibroblasts. Recently, it was reported less important role in the regulation of ubiquitously ex-
that smooth muscle differentiation marker gene expres- pressed genes such as non-muscle  actin. Moreover, it
sion is regulated by Rho-mediated actin polymerization was reported that myofibroblast contraction is reduced
and that Y-27632 administration inhibited the synthesis by Y-27632 [40]. These findings are of interest because
of SMA isoform to a greater extent than the ubiqui- the appearance of myofibroblasts has also been consid-
tously expressed  actin isoform [39]. These observations ered to play a key role in the progression of fibrosis not
suggested that the Rho-ROCK signaling pathway plays only in the renal interstitium, but also in the renal glo-
merulus [29, 41], liver [42], lung [43] and pancreas [44],an important role in the regulation of smooth muscle
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which suggests that Y-27632 may be efficacious for pro- our present data, it is possible that Ang II contributes
gressive proliferative glomerulonephritis, hepatic fibro- to development of interstitial fibrosis by promoting the
sis, interstitial pneumonitis and pancreatitis. In the con- migration of macrophages.
tralateral kidney, positive staining for SMA was seen The inhibitory effect of Y-27632 on cell proliferation
only in the vascular smooth muscle cells, and Y-27632 is still controversial. In the present study, Y-27632 did
treatment seemed to have no effect on these stainings. not show any inhibitory effect on mouse renal fibroblast
Y-27632 suppressed TGF-mRNA expression in vivo proliferation. It was also reported that Y-27632 did not
in the present study. Several reports have shown that inhibit the proliferation of FCS-stimulated human umbil-
TGF- signaling is regulated by Rho [45–47] and our ical vein endothelial cells [56]. However, it has been
present data support these reports. Since the blockade reported that Y-27632 inhibited thrombin-stimulated
of TGF- signaling is known to suppress renal interstitial DNA synthesis in rat aortic smooth muscle cell [57].
fibrosis in UUO model kidney [48], the effect of Y-27632 Ishizaki and colleagues reported that Y-27632 abolished
treatment might partly be due to suppression of TGF- stress fibers in Swiss 3T3 cells at 10 mol/L, but the G1
expression. In cultured fibroblast, reductions of neither to S phase transition and cytokinesis were little affected
1(I) collagen nor TGF- mRNA levels were not sig- at this concentration and they were affected at concentra-
nificant. The dissociation between in vivo experiment tions as high as 100 mol/L [26].
and in vitro one remains to be elucidated, but one possi- In summary, the results presented here indicated the
ble explanation is as follows. In the development of renal effects of Y-27632 on interstitial fibrosis and myofibroblast
interstitial fibrosis, tubular cells and infiltrated macro- expansion in mouse kidneys with unilateral ureteral ob-
phages are supposed to play important roles by the in- struction. Interstitial fibrosis was significantly improved
fluencing the surrounding renal fibroblasts. In Y-27632 along with decreases in SMA and F4/80 immunostaining.
treated kidney, Y-27632 might have indirectly affected Northern blot analyses also indicated that 1 (I) collagen,
renal fibroblasts through the inhibition of activated tubu- SMA and TGF- mRNA expressions were suppressed
lar cells and/or infiltrated macrophages, which resulted by Y-27632. In addition, Y-27632 inhibited macrophage
in the reduction of 1(I) collagen and TGF- mRNA migration.
expressions in the in vivo experiment. In conclusion, the Rho-ROCK system may play an
Macrophage infiltration, one of the key mechanisms important role in the development of tissue fibrosis and
involved in the progression of interstitial fibrosis, was may be a new therapeutic target for preventing intersti-
suppressed by Y-27632. Several mechanisms seemed to tial fibrosis in progressive renal disease.
be related to the reduction of macrophage infiltration.
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